JT Hagen, MM Montgomery, RT Aruleba, BR Chrest… - bioRxiv, 2024 - ncbi.nlm.nih.gov
Despite early optimism, therapeutics targeting oxidative phosphorylation (OxPhos) have
faced clinical setbacks, stemming from their inability to distinguish healthy from cancerous …